Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $8.13 | Prev. Close $8.36 | Circuit Range N/A |
Day Range $7.58 - $8.13 | Year Range $0.46 - $8.83 | Volume 3,487 |
Average Traded $7.77 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-May-26 | $7.96 | $7.95 | -2.69% |
11-May-26 | $8.42 | $8.17 | -4.44% |
08-May-26 | $8.59 | $8.55 | +1.73% |
07-May-26 | $8.54 | $8.40 | -1.81% |
06-May-26 | $8.70 | $8.56 | +0.18% |
05-May-26 | $8.66 | $8.54 | +0.71% |
04-May-26 | $8.29 | $8.48 | +2.97% |